Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$6,707,212
+$916,324 QoQ
Shares Held
26,654
+0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#1,135
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INTRUST BANK NA holds $44,865,794 across 13 Drug Manufacturers - General names. ABBV ranks #2 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,489 | $13,780,251 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
26,654 | $6,707,212 | |
| 3 | JNJ |
Johnson & Johnson
|
24,382 | $6,192,296 | |
| 4 | MRK |
Merck & Co., Inc.
|
28,996 | $3,725,986 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
24,402 | $3,082,948 | |
| 6 | AMGN |
Amgen Inc
|
7,840 | $2,839,020 | |
| 7 | AZN |
Astrazeneca PLC
|
10,427 | $1,977,167 | |
| 8 | NVS |
Novartis AG
|
11,153 | $1,747,897 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,707,212 | 26,654 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $5,790,888 | 26,626 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $5,841,802 | 25,567 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $5,889,682 | 25,437 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,618,781 | 24,883 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,036,651 | 24,039 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $4,109,667 | 23,127 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,485,165 | 22,712 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,899,335 | 22,734 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,212,519 | 23,133 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,643,344 | 23,510 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $3,453,570 | 23,169 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,991,409 | 22,203 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,745,194 | 23,500 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $3,783,451 | 23,411 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,018,114 | 22,488 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,605,538 | 23,541 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $4,115,810 | 25,389 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,364,825 | 24,851 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $2,625,231 | 24,337 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $2,786,825 | 24,741 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,574,120 | 23,786 | Shares | Sole | 2021-06-02 | |
| 2020-12-31 | $2,485,558 | 23,197 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,136,932 | 24,397 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $2,209,638 | 22,506 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,535,532 | 20,154 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||